Myomo Inc, a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces that the Healthcare Quality Association on Accreditation (HQAA) has certified Myomo meets the accreditation requirements under the Social Security Act and federal regulations.
Accreditation is a program in which trained external peer reviewers evaluate a healthcare organization’s compliance and compare it with pre-established performance standards.
In September 2020, the Company announced that the Centers for Medicare & Medicaid Services (CMS) under the U.S. Department of Health and Human Services had authorized the Company to be a Medicare Provider. This authorization required the Company to become accredited, and it has now met that requirement.
“Today, reimbursement for the MyoPro orthosis is approved on a case-by-case basis by many Medicare Advantage plans, state Blue Cross / Blue Shield plans, certain Medicaid and commercial insurance plans, worker’s compensation plans, and the Veterans Administration. Obtaining broader coverage would allow us to potentially better serve the qualifying beneficiaries of Medicare and other plans who suffer a paralyzed or weakened arm caused by stroke or nerve injury.
“I want to emphasize that we have not yet received coverage or reimbursement terms from CMS, and in fact there is no guarantee those terms will be forthcoming soon. Nonetheless, accredited provider status is an important step following on to our receiving Healthcare Common Procedure Coding System (HCPCS) codes from CMS and demonstrates we have the infrastructure in place to support Medicare patients when we have coverage from Medicare. We will continue to advocate for MyoPro coverage to help appropriate candidates obtain this useful technology for use at home, at work, and in school.”
— Paul R. Gudonis, Myomo CEO
[Source(s): Myomo Inc, Business Wire]
Myomo Receives Certification as a Medicare Provider
HCPCS Code Change for MyoPro Brace Hits a Snag